
|Videos|October 15, 2015
Dr. S Yousuf Zafar Talks About BMI and Survival Rates in Colorectal Cancer Patients
Dr. S. Yousuf Zafar talks about the association between the body mass index of patients who are starting treatment for colorectal cancer and both the progression free survival and overall survival.
Advertisement
S. Yousuf Zafar, MD, Associate Professor of Medicine at Duke Cancer Institute, talks about the association between the body mass index (BMI) of patients who are starting treatment for colorectal cancer and both the progression free survival (PFS) and overall survival (OS).
Zafar says that while there was no link to be drawn between PFS and BMI in those patients, there was a connection between higher BMI and a better OS rate.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Approves Iberdomide, the First CELMoD for Relapsed/Refractory Multiple Myeloma
2
How the Immune System Drives Nerve Growth in TNBC
3
AMH Testing Predicts Chemotherapy Benefit in RxPONDER Breast Cancer
4
FAQ: When and How to Discontinue Lenalidomide Maintenance in Multiple Myeloma
5



































